 Mylan N.V. NASDAQ: MYL today announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the consumer level of one lot of Daptomycin for Injection, 500 mgvial due to the presence of particulate matter found in one single-dose vial manufactured by Mylan Laboratories Limiteds Specialty Formulation Facility. To date, Mylan has not received any reports of adverse events related to this recall. 